Understanding how tick signaling affects disease transmission
Signaling Pathways Regulating Vector Immune-Developmental Cascades
This study is looking at how black-legged ticks, which can spread Lyme disease and anaplasmosis, respond to what they eat and how that affects their ability to fight off germs, with the hope of creating vaccines to help prevent these diseases.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of Maryland, College Park NIH-funded |
| Lab location | 1 site (College Park, United States) |
| Project ID | NIH-11112744 on NIH RePORTER |
What this research studies
This research investigates the signaling pathways in black-legged ticks that influence their immune responses and ability to transmit diseases like Lyme disease and anaplasmosis. By studying the Ixodes scapularis tick, the project aims to identify specific components that could be targeted by vaccines to prevent these diseases. The approach involves examining how ticks respond to substances in their blood meals, which may enhance their ability to fight off pathogens. The ultimate goal is to develop effective anti-tick vaccines that can reduce the transmission of these serious infections.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living in areas where Lyme disease and anaplasmosis are prevalent, particularly those who frequently encounter ticks.
Not a fit: Patients who do not live in tick-infested areas or who are not at risk for tick-borne diseases may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of vaccines that significantly reduce the incidence of Lyme disease and anaplasmosis in humans.
How similar studies have performed: Previous research has shown promise in targeting tick signaling pathways for vaccine development, indicating that this approach could be effective.
Where this research is happening
College Park, United States
- Univ of Maryland, College Park — College Park, United States (Active)
Researchers
- Principal investigator: Pal, Utpal — Univ of Maryland, College Park
- Study coordinator: Pal, Utpal
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.